Article Text

PDF
L-dopa and amantadine for parkinsonism

Abstract

Since we discussed L-dopa last year1 the drug has been marketed as Larodopa (Roche) and Brocadopa (Brocades), many further reports on it have been published,2–6 and the lay press has at times exaggerated both its benefits and its adverse effects. Meanwhile another new drug, amantadine (Symmetrel - Geigy), has also been introduced for Parkinsonism.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.